Global Colorectal Cancer Drugs Sales Market Report 2021

Global Colorectal Cancer Drugs Sales Market Report 2021

Table of Contents
1 Colorectal Cancer Drugs Market Overview
1.1 Colorectal Cancer Drugs Product Scope
1.2 Colorectal Cancer Drugs Segment
1.2.1 Global Colorectal Cancer Drugs Sales (2016 & 2021 & 2027)
1.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
1.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
1.2.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
1.2.5 BRAF or MEK Inhibitors
1.2.6 Tyrosine Kinase (TKI) Inhibitors
1.2.7 Immunomodulators
1.3 Colorectal Cancer Drugs Segment
1.3.1 Global Colorectal Cancer Drugs Sales Comparison (2016 & 2021 & 2027)
1.3.2 Radiotherapy
1.3.3 Chemotherapy
1.4 Colorectal Cancer Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Colorectal Cancer Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Colorectal Cancer Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Colorectal Cancer Drugs Price Trends (2016-2027)
2 Colorectal Cancer Drugs Estimates and Forecasts by Region
2.1 Global Colorectal Cancer Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Colorectal Cancer Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Colorectal Cancer Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Colorectal Cancer Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Colorectal Cancer Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Colorectal Cancer Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Colorectal Cancer Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Colorectal Cancer Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Colorectal Cancer Drugs Estimates and Projections (2016-2027)
2.4.3 China Colorectal Cancer Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Colorectal Cancer Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Colorectal Cancer Drugs Estimates and Projections (2016-2027)
2.4.6 India Colorectal Cancer Drugs Estimates and Projections (2016-2027)
3 Global Colorectal Cancer Drugs Competition Landscape by Players
3.1 Global Top Colorectal Cancer Drugs Players by Sales (2016-2021)
3.2 Global Top Colorectal Cancer Drugs Players by Revenue (2016-2021)
3.3 Global Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Colorectal Cancer Drugs as of 2020)
3.4 Global Colorectal Cancer Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Colorectal Cancer Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Colorectal Cancer Drugs Market Size
4.1 Global Colorectal Cancer Drugs Historic Market Review (2016-2021)
4.1.1 Global Colorectal Cancer Drugs Sales Market Share (2016-2021)
4.1.2 Global Colorectal Cancer Drugs Revenue Market Share (2016-2021)
4.1.3 Global Colorectal Cancer Drugs Price (2016-2021)
4.2 Global Colorectal Cancer Drugs Market Estimates and Forecasts (2022-2027)
4.2.1 Global Colorectal Cancer Drugs Sales Forecast (2022-2027)
4.2.2 Global Colorectal Cancer Drugs Revenue Forecast (2022-2027)
4.2.3 Global Colorectal Cancer Drugs Price Forecast (2022-2027)
5 Global Colorectal Cancer Drugs Market Size
5.1 Global Colorectal Cancer Drugs Historic Market Review (2016-2021)
5.1.1 Global Colorectal Cancer Drugs Sales Market Share (2016-2021)
5.1.2 Global Colorectal Cancer Drugs Revenue Market Share (2016-2021)
5.1.3 Global Colorectal Cancer Drugs Price (2016-2021)
5.2 Global Colorectal Cancer Drugs Market Estimates and Forecasts (2022-2027)
5.2.1 Global Colorectal Cancer Drugs Sales Forecast (2022-2027)
5.2.2 Global Colorectal Cancer Drugs Revenue Forecast (2022-2027)
5.2.3 Global Colorectal Cancer Drugs Price Forecast (2022-2027)
6 North America Colorectal Cancer Drugs Market Facts & Figures
6.1 North America Colorectal Cancer Drugs Sales by Company
6.1.1 North America Colorectal Cancer Drugs Sales by Company (2016-2021)
6.1.2 North America Colorectal Cancer Drugs Revenue by Company (2016-2021)
6.2 North America Colorectal Cancer Drugs Sales Breakdown
6.2.1 North America Colorectal Cancer Drugs Sales Breakdown (2016-2021)
6.2.2 North America Colorectal Cancer Drugs Sales Breakdown (2022-2027)
6.3 North America Colorectal Cancer Drugs Sales Breakdown
6.3.1 North America Colorectal Cancer Drugs Sales Breakdown (2016-2021)
6.3.2 North America Colorectal Cancer Drugs Sales Breakdown (2022-2027)
7 Europe Colorectal Cancer Drugs Market Facts & Figures
7.1 Europe Colorectal Cancer Drugs Sales by Company
7.1.1 Europe Colorectal Cancer Drugs Sales by Company (2016-2021)
7.1.2 Europe Colorectal Cancer Drugs Revenue by Company (2016-2021)
7.2 Europe Colorectal Cancer Drugs Sales Breakdown
7.2.1 Europe Colorectal Cancer Drugs Sales Breakdown (2016-2021)
7.2.2 Europe Colorectal Cancer Drugs Sales Breakdown (2022-2027)
7.3 Europe Colorectal Cancer Drugs Sales Breakdown
7.3.1 Europe 144 Sales Breakdown (2016-2021)
7.3.2 Europe 144 Sales Breakdown (2022-2027)
8 China Colorectal Cancer Drugs Market Facts & Figures
8.1 China Colorectal Cancer Drugs Sales by Company
8.1.1 China Colorectal Cancer Drugs Sales by Company (2016-2021)
8.1.2 China Colorectal Cancer Drugs Revenue by Company (2016-2021)
8.2 China Colorectal Cancer Drugs Sales Breakdown
8.2.1 China Colorectal Cancer Drugs Sales Breakdown (2016-2021)
8.2.2 China Colorectal Cancer Drugs Sales Breakdown (2022-2027)
8.3 China Colorectal Cancer Drugs Sales Breakdown
8.3.1 China 311 Sales Breakdown (2016-2021)
8.3.2 China 311 Sales Breakdown (2022-2027)
9 Japan Colorectal Cancer Drugs Market Facts & Figures
9.1 Japan Colorectal Cancer Drugs Sales by Company
9.1.1 Japan Colorectal Cancer Drugs Sales by Company (2016-2021)
9.1.2 Japan Colorectal Cancer Drugs Revenue by Company (2016-2021)
9.2 Japan Colorectal Cancer Drugs Sales Breakdown
9.2.1 Japan Colorectal Cancer Drugs Sales Breakdown (2016-2021)
9.2.2 Japan Colorectal Cancer Drugs Sales Breakdown (2022-2027)
9.3 Japan Colorectal Cancer Drugs Sales Breakdown
9.3.1 Japan Feb. Sales Breakdown (2016-2021)
9.3.2 Japan Feb. Sales Breakdown (2022-2027)
10 Southeast Asia Colorectal Cancer Drugs Market Facts & Figures
10.1 Southeast Asia Colorectal Cancer Drugs Sales by Company
10.1.1 Southeast Asia Colorectal Cancer Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Colorectal Cancer Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Colorectal Cancer Drugs Sales Breakdown
10.2.1 Southeast Asia Colorectal Cancer Drugs Sales Breakdown (2016-2021)
10.2.2 Southeast Asia Colorectal Cancer Drugs Sales Breakdown (2022-2027)
10.3 Southeast Asia Colorectal Cancer Drugs Sales Breakdown
10.3.1 Southeast Asia MT Sales Breakdown (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown (2022-2027)
11 India Colorectal Cancer Drugs Market Facts & Figures
11.1 India Colorectal Cancer Drugs Sales by Company
11.1.1 India Colorectal Cancer Drugs Sales by Company (2016-2021)
11.1.2 India Colorectal Cancer Drugs Revenue by Company (2016-2021)
11.2 India Colorectal Cancer Drugs Sales Breakdown
11.2.1 India Colorectal Cancer Drugs Sales Breakdown (2016-2021)
11.2.2 India Colorectal Cancer Drugs Sales Breakdown (2022-2027)
11.3 India Colorectal Cancer Drugs Sales Breakdown
11.3.1 India Colorectal Cancer Drugs Sales Breakdown (2016-2021)
11.3.2 India Colorectal Cancer Drugs Sales Breakdown (2022-2027)
12 Company Profiles and Key Figures in Colorectal Cancer Drugs Business
12.1 AB Science
12.1.1 AB Science Corporation Information
12.1.2 AB Science Business Overview
12.1.3 AB Science Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AB Science Colorectal Cancer Drugs Products Offered
12.1.5 AB Science Recent Development
12.2 Amgen
12.2.1 Amgen Corporation Information
12.2.2 Amgen Business Overview
12.2.3 Amgen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Amgen Colorectal Cancer Drugs Products Offered
12.2.5 Amgen Recent Development
12.3 Array BioPharma
12.3.1 Array BioPharma Corporation Information
12.3.2 Array BioPharma Business Overview
12.3.3 Array BioPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Array BioPharma Colorectal Cancer Drugs Products Offered
12.3.5 Array BioPharma Recent Development
12.4 Bayer
12.4.1 Bayer Corporation Information
12.4.2 Bayer Business Overview
12.4.3 Bayer Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bayer Colorectal Cancer Drugs Products Offered
12.4.5 Bayer Recent Development
12.5 Boehringer Ingelheim
12.5.1 Boehringer Ingelheim Corporation Information
12.5.2 Boehringer Ingelheim Business Overview
12.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Products Offered
12.5.5 Boehringer Ingelheim Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Business Overview
12.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Elli Lilly
12.7.1 Elli Lilly Corporation Information
12.7.2 Elli Lilly Business Overview
12.7.3 Elli Lilly Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Elli Lilly Colorectal Cancer Drugs Products Offered
12.7.5 Elli Lilly Recent Development
12.8 Roch
12.8.1 Roch Corporation Information
12.8.2 Roch Business Overview
12.8.3 Roch Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Roch Colorectal Cancer Drugs Products Offered
12.8.5 Roch Recent Development
12.9 Hutchison MediPharma
12.9.1 Hutchison MediPharma Corporation Information
12.9.2 Hutchison MediPharma Business Overview
12.9.3 Hutchison MediPharma Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hutchison MediPharma Colorectal Cancer Drugs Products Offered
12.9.5 Hutchison MediPharma Recent Development
12.10 Merck & Co., Inc.
12.10.1 Merck & Co., Inc. Corporation Information
12.10.2 Merck & Co., Inc. Business Overview
12.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Merck & Co., Inc. Colorectal Cancer Drugs Products Offered
12.10.5 Merck & Co., Inc. Recent Development
12.11 Mologen
12.11.1 Mologen Corporation Information
12.11.2 Mologen Business Overview
12.11.3 Mologen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Mologen Colorectal Cancer Drugs Products Offered
12.11.5 Mologen Recent Development
12.12 Regeneron
12.12.1 Regeneron Corporation Information
12.12.2 Regeneron Business Overview
12.12.3 Regeneron Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Regeneron Colorectal Cancer Drugs Products Offered
12.12.5 Regeneron Recent Development
12.13 Sanofi
12.13.1 Sanofi Corporation Information
12.13.2 Sanofi Business Overview
12.13.3 Sanofi Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Sanofi Colorectal Cancer Drugs Products Offered
12.13.5 Sanofi Recent Development
12.14 Sumitomo Dainippon
12.14.1 Sumitomo Dainippon Corporation Information
12.14.2 Sumitomo Dainippon Business Overview
12.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Sumitomo Dainippon Colorectal Cancer Drugs Products Offered
12.14.5 Sumitomo Dainippon Recent Development
12.15 Taiho Pharmaceutical
12.15.1 Taiho Pharmaceutical Corporation Information
12.15.2 Taiho Pharmaceutical Business Overview
12.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Taiho Pharmaceutical Colorectal Cancer Drugs Products Offered
12.15.5 Taiho Pharmaceutical Recent Development
12.16 Vaccinogen
12.16.1 Vaccinogen Corporation Information
12.16.2 Vaccinogen Business Overview
12.16.3 Vaccinogen Colorectal Cancer Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Vaccinogen Colorectal Cancer Drugs Products Offered
12.16.5 Vaccinogen Recent Development
13 Colorectal Cancer Drugs Manufacturing Cost Analysis
13.1 Colorectal Cancer Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Colorectal Cancer Drugs
13.4 Colorectal Cancer Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Colorectal Cancer Drugs Distributors List
14.3 Colorectal Cancer Drugs Customers
15 Market Dynamics
15.1 Colorectal Cancer Drugs Market Trends
15.2 Colorectal Cancer Drugs Drivers
15.3 Colorectal Cancer Drugs Market Challenges
15.4 Colorectal Cancer Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Colorectal Cancer Drugs Sales (US$ Million) Growth Rate (2016 & 2021 & 2027)
Table 2. Global Colorectal Cancer Drugs Sales ((US$ Million)) Comparison (2016 & 2021 & 2027)
Table 3. Global Colorectal Cancer Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Colorectal Cancer Drugs Sales (MT) by Region (2016-2021)
Table 5. Global Colorectal Cancer Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Colorectal Cancer Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Colorectal Cancer Drugs Revenue Share by Region (2016-2021)
Table 8. Global Colorectal Cancer Drugs Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Colorectal Cancer Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Colorectal Cancer Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Colorectal Cancer Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Colorectal Cancer Drugs Sales (MT) of Key Companies (2016-2021)
Table 13. Global Colorectal Cancer Drugs Sales Share by Company (2016-2021)
Table 14. Global Colorectal Cancer Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Colorectal Cancer Drugs Revenue Share by Company (2016-2021)
Table 16. Global Colorectal Cancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Drugs as of 2020)
Table 17. Global Colorectal Cancer Drugs Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Colorectal Cancer Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Colorectal Cancer Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Colorectal Cancer Drugs Sales (MT) (2016-2021)
Table 22. Global Colorectal Cancer Drugs Sales Share (2016-2021)
Table 23. Global Colorectal Cancer Drugs Revenue (US$ Million) Market Share (2016-2021)
Table 24. Global Colorectal Cancer Drugs Price (USD/Kg) (2016-2021)
Table 25. Global Colorectal Cancer Drugs Sales Share (2022-2027)
Table 26. Global Colorectal Cancer Drugs Revenue (US$ Million) Market Share (2022-2027)
Table 27. Global Colorectal Cancer Drugs Revenue Share (2022-2027)
Table 28. Global Colorectal Cancer Drugs Price (USD/Kg) (2022-2027)
Table 29. Global Colorectal Cancer Drugs Sales (MT) (2016-2021)
Table 30. Global Colorectal Cancer Drugs Sales Share (2016-2021)
Table 31. Global Colorectal Cancer Drugs Revenue (US$ Million) Market Share (2016-2021)
Table 32. Global Colorectal Cancer Drugs Price (USD/Kg) (2016-2021)
Table 33. Global Colorectal Cancer Drugs Sales (MT) (2022-2027)
Table 34. Global Colorectal Cancer Drugs Sales Share (2022-2027)
Table 35. Global Colorectal Cancer Drugs Revenue (US$ Million) Market Share (2022-2027)
Table 36. Global Colorectal Cancer Drugs Revenue Share (2022-2027)
Table 37. Global Colorectal Cancer Drugs Price (USD/Kg) (2022-2027)
Table 38. North America Colorectal Cancer Drugs Sales (MT) by Company (2016-2021)
Table 39. North America Colorectal Cancer Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Colorectal Cancer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Colorectal Cancer Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 43. North America Colorectal Cancer Drugs Sales Market Share (2016-2021)
Table 44. North America Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 45. North America Colorectal Cancer Drugs Sales Market Share (2022-2027)
Table 46. North America Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 47. North America Colorectal Cancer Drugs Sales Market Share (2016-2021)
Table 48. North America Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 49. North America Colorectal Cancer Drugs Sales Market Share (2022-2027)
Table 50. Europe Colorectal Cancer Drugs Sales (MT) by Company (2016-2021)
Table 51. Europe Colorectal Cancer Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Colorectal Cancer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Colorectal Cancer Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 55. Europe Colorectal Cancer Drugs Sales Market Share (2016-2021)
Table 56. Europe Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 57. Europe Colorectal Cancer Drugs Sales Market Share (2022-2027)
Table 58. Europe Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 59. Europe Colorectal Cancer Drugs Sales Market Share (2016-2021)
Table 60. Europe Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 61. Europe Colorectal Cancer Drugs Sales Market Share (2022-2027)
Table 62. China Colorectal Cancer Drugs Sales (MT) by Company (2016-2021)
Table 63. China Colorectal Cancer Drugs Sales Market Share by Company (2016-2021)
Table 64. China Colorectal Cancer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Colorectal Cancer Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 67. China Colorectal Cancer Drugs Sales Market Share (2016-2021)
Table 68. China Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 69. China Colorectal Cancer Drugs Sales Market Share (2022-2027)
Table 70. China Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 71. China Colorectal Cancer Drugs Sales Market Share (2016-2021)
Table 72. China Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 73. China Colorectal Cancer Drugs Sales Market Share (2022-2027)
Table 74. Japan Colorectal Cancer Drugs Sales (MT) by Company (2016-2021)
Table 75. Japan Colorectal Cancer Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Colorectal Cancer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Colorectal Cancer Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 79. Japan Colorectal Cancer Drugs Sales Market Share (2016-2021)
Table 80. Japan Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 81. Japan Colorectal Cancer Drugs Sales Market Share (2022-2027)
Table 82. Japan Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 83. Japan Colorectal Cancer Drugs Sales Market Share (2016-2021)
Table 84. Japan Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 85. Japan Colorectal Cancer Drugs Sales Market Share (2022-2027)
Table 86. Southeast Asia Colorectal Cancer Drugs Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Colorectal Cancer Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Colorectal Cancer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Colorectal Cancer Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 91. Southeast Asia Colorectal Cancer Drugs Sales Market Share (2016-2021)
Table 92. Southeast Asia Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 93. Southeast Asia Colorectal Cancer Drugs Sales Market Share (2022-2027)
Table 94. Southeast Asia Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 95. Southeast Asia Colorectal Cancer Drugs Sales Market Share (2016-2021)
Table 96. Southeast Asia Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 97. Southeast Asia Colorectal Cancer Drugs Sales Market Share (2022-2027)
Table 98. India Colorectal Cancer Drugs Sales (MT) by Company (2016-2021)
Table 99. India Colorectal Cancer Drugs Sales Market Share by Company (2016-2021)
Table 100. India Colorectal Cancer Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Colorectal Cancer Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 103. India Colorectal Cancer Drugs Sales Market Share (2016-2021)
Table 104. India Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 105. India Colorectal Cancer Drugs Sales Market Share (2022-2027)
Table 106. India Colorectal Cancer Drugs Sales (2016-2021) & (MT)
Table 107. India Colorectal Cancer Drugs Sales Market Share (2016-2021)
Table 108. India Colorectal Cancer Drugs Sales (2022-2027) & (MT)
Table 109. India Colorectal Cancer Drugs Sales Market Share (2022-2027)
Table 110. AB Science Corporation Information
Table 111. AB Science Description and Business Overview
Table 112. AB Science Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. AB Science Colorectal Cancer Drugs Product
Table 114. AB Science Recent Development
Table 115. Amgen Corporation Information
Table 116. Amgen Description and Business Overview
Table 117. Amgen Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Amgen Colorectal Cancer Drugs Product
Table 119. Amgen Recent Development
Table 120. Array BioPharma Corporation Information
Table 121. Array BioPharma Description and Business Overview
Table 122. Array BioPharma Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Array BioPharma Colorectal Cancer Drugs Product
Table 124. Array BioPharma Recent Development
Table 125. Bayer Corporation Information
Table 126. Bayer Description and Business Overview
Table 127. Bayer Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Bayer Colorectal Cancer Drugs Product
Table 129. Bayer Recent Development
Table 130. Boehringer Ingelheim Corporation Information
Table 131. Boehringer Ingelheim Description and Business Overview
Table 132. Boehringer Ingelheim Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Boehringer Ingelheim Colorectal Cancer Drugs Product
Table 134. Boehringer Ingelheim Recent Development
Table 135. Bristol-Myers Squibb Corporation Information
Table 136. Bristol-Myers Squibb Description and Business Overview
Table 137. Bristol-Myers Squibb Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Bristol-Myers Squibb Colorectal Cancer Drugs Product
Table 139. Bristol-Myers Squibb Recent Development
Table 140. Elli Lilly Corporation Information
Table 141. Elli Lilly Description and Business Overview
Table 142. Elli Lilly Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. Elli Lilly Colorectal Cancer Drugs Product
Table 144. Elli Lilly Recent Development
Table 145. Roch Corporation Information
Table 146. Roch Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. Roch Description and Business Overview
Table 148. Roch Colorectal Cancer Drugs Product
Table 149. Roch Recent Development
Table 150. Hutchison MediPharma Corporation Information
Table 151. Hutchison MediPharma Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. Hutchison MediPharma Description and Business Overview
Table 153. Hutchison MediPharma Colorectal Cancer Drugs Product
Table 154. Hutchison MediPharma Recent Development
Table 155. Merck & Co., Inc. Corporation Information
Table 156. Merck & Co., Inc. Description and Business Overview
Table 157. Merck & Co., Inc. Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. Merck & Co., Inc. Colorectal Cancer Drugs Product
Table 159. Merck & Co., Inc. Recent Development
Table 160. Mologen Corporation Information
Table 161. Mologen Description and Business Overview
Table 162. Mologen Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. Mologen Colorectal Cancer Drugs Product
Table 164. Mologen Recent Development
Table 165. Regeneron Corporation Information
Table 166. Regeneron Description and Business Overview
Table 167. Regeneron Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 168. Regeneron Colorectal Cancer Drugs Product
Table 169. Regeneron Recent Development
Table 170. Sanofi Corporation Information
Table 171. Sanofi Description and Business Overview
Table 172. Sanofi Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 173. Sanofi Colorectal Cancer Drugs Product
Table 174. Sanofi Recent Development
Table 175. Sumitomo Dainippon Corporation Information
Table 176. Sumitomo Dainippon Description and Business Overview
Table 177. Sumitomo Dainippon Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 178. Sumitomo Dainippon Colorectal Cancer Drugs Product
Table 179. Sumitomo Dainippon Recent Development
Table 180. Taiho Pharmaceutical Corporation Information
Table 181. Taiho Pharmaceutical Description and Business Overview
Table 182. Taiho Pharmaceutical Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 183. Taiho Pharmaceutical Colorectal Cancer Drugs Product
Table 184. Taiho Pharmaceutical Recent Development
Table 185. Vaccinogen Corporation Information
Table 186. Vaccinogen Description and Business Overview
Table 187. Vaccinogen Colorectal Cancer Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 188. Vaccinogen Colorectal Cancer Drugs Product
Table 189. Vaccinogen Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Colorectal Cancer Drugs Distributors List
Table 193. Colorectal Cancer Drugs Customers List
Table 194. Colorectal Cancer Drugs Market Trends
Table 195. Colorectal Cancer Drugs Market Drivers
Table 196. Colorectal Cancer Drugs Market Challenges
Table 197. Colorectal Cancer Drugs Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Colorectal Cancer Drugs Product Picture
Figure 2. Global Colorectal Cancer Drugs Sales Market Share in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Colorectal Cancer Drugs Sales Market Share in 2021 & 2027
Figure 6. Radiotherapy Examples
Figure 7. Chemotherapy Examples
Figure 8. Global Colorectal Cancer Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Colorectal Cancer Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Colorectal Cancer Drugs Sales (MT) Growth Rate (2016-2027)
Figure 11. Global Colorectal Cancer Drugs Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 12. Global Colorectal Cancer Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Colorectal Cancer Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Colorectal Cancer Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Colorectal Cancer Drugs Sales (MT) Growth Rate (2016-2027)
Figure 16. Europe Colorectal Cancer Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Colorectal Cancer Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Colorectal Cancer Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Colorectal Cancer Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Colorectal Cancer Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Colorectal Cancer Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Colorectal Cancer Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Colorectal Cancer Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Colorectal Cancer Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Colorectal Cancer Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Colorectal Cancer Drugs Players Market Share by Revenue in Colorectal Cancer Drugs: 2016 & 2020
Figure 27. Colorectal Cancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Colorectal Cancer Drugs Revenue Share (2016-2021)
Figure 29. Global Colorectal Cancer Drugs Revenue Growth Rate in 2016 & 2020
Figure 30. Global Colorecta

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs